Document ID: chunk:federal_register_of_legislation:F2025C00124:clause:3_1:p55
Version: federal_register_of_legislation:F2025C00124
Segment Type: clause
Provision Reference: sch 3 cl 1 (pt 55/476)
Character Range: 1087415–1097172

must have chronic kidney disease; AND
                                                                                                                                            Patient must be on dialysis; AND
                                                                                                                                            Patient must have failed to respond to conventional therapy; AND
                                                                                                                                            Patient must have sustained hyperparathyroidism with iPTH of at least 50 pmol per L; OR
                                                                                                                                            Patient must have sustained hyperparathyroidism with iPTH of at least 15 pmol per L and less than 50 pmol per L and an (adjusted) serum calcium concentration at least 2.6 mmol per L.
                                                                                                                                            During the titration phase, intact PTH (iPTH) should be monitored 4 weekly (measured at least 12 hours post dose) and dose titrated until an appropriate iPTH concentration is achieved.
                                                                                                                                            During the titration phase, prescribers should request approval to allow sufficient supply for 4 weeks treatment at a time, with doses between 30 and 180 mg per day according to the patient's response and tolerability.
Clozapine                                                              C4998                                                                Schizophrenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures ‑ Streamlined Authority Code 4998
                                                                                                                                            Continuing treatment
                                                                                                                                            Must be treated by a psychiatrist; OR
                                                                                                                                            Must be treated by an authorised medical practitioner, with the agreement of the treating psychiatrist.
                                                                                                                                            Patient must have previously received PBS‑subsidised therapy with this drug for this condition; AND
                                                                                                                                            Patient must have completed at least 18 weeks therapy; AND
                                                                                                                                            Patient must be on a clozapine dosage considered stable by a treating psychiatrist; AND
                                                                                                                                            The treatment must be under the supervision and direction of a psychiatrist reviewing the patient at regular intervals.
                                                                                                                                            A medical practitioner should request a quantity sufficient for up to one month's supply. Up to 5 repeats will be authorised.
                                                                       C5015                                                                Schizophrenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures ‑ Streamlined Authority Code 5015
                                                                                                                                            Initial treatment
                                                                                                                                            Must be treated by a psychiatrist or in consultation with the psychiatrist affiliated with the hospital or specialised unit managing the patient.
                                                                                                                                            Patient must be non‑responsive to other neuroleptic agents; OR
                                                                                                                                            Patient must be intolerant of other neuroleptic agents.
                                                                                                                                            Patients must complete at least 18 weeks of initial treatment under this restriction before being able to qualify for treatment under the continuing restriction.
                                                                                                                                            The name of the consulting psychiatrist should be included in the patient's medical records.
                                                                                                                                            A medical practitioner should request a quantity sufficient for up to one month's supply. Up to 5 repeats will be authorised.
                                                                       C9490                                                                Schizophrenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures ‑ Streamlined Authority Code 9490
                                                                                                                                            Initial treatment
                                                                                                                                            Must be treated by a psychiatrist or in consultation with the psychiatrist affiliated with the hospital or specialised unit managing the patient.
                                                                                                                                            Patient must be non‑responsive to other neuroleptic agents; OR
                                                                                                                                            Patient must be intolerant of other neuroleptic agents.
                                                                                                                                            Patients must complete at least 18 weeks of initial treatment under this restriction before being able to qualify for treatment under the continuing restriction.
                                                                                                                                            The name of the consulting psychiatrist should be included in the patient's medical